Actively Recruiting

Age: 18Years +
All Genders
NCT07264959

An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)

Led by Blueprint Medicines Corporation · Updated on 2026-04-22

150

Participants Needed

1

Research Sites

346 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a Phase 4, non-interventional, observational study to collect detailed data on the clinical characteristics, clinical outcomes and medical management of ISM in real-world settings. The study will describe the demographic and clinical characteristics of ISM participants, including anaphylaxis and bone manifestations in ISM. Quality of life and disease control will be assessed through participant questionnaires. The study will also evaluate real world ISM treatment management, including use of avapritinib.

CONDITIONS

Official Title

An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female adults aged 18 years or older with a diagnosis of Indolent Systemic Mastocytosis (ISM) according to World Health Organization criteria
  • Currently being treated or planning to be treated with symptom-directed therapies and/or avapritinib for ISM
Not Eligible

You will not qualify if you...

  • Diagnosis of advanced systemic mastocytosis (AdvSM) or another associated hematologic neoplasm
  • Diagnosis of smoldering systemic mastocytosis
  • Currently participating in interventional studies in systemic mastocytosis at enrollment
  • Receiving treatment with a KIT inhibitor other than avapritinib at enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Brigham and Women's Allergy and Clinical Immunology, Mass General Brigham Healthcare Center (Chestnut Hill)

Chestnut Hill, Massachusetts, United States, 02467

Actively Recruiting

Loading map...

Research Team

B

Blueprint Medicines

CONTACT

B

Blueprint Medicines, EU Contact

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here